People with schizophrenia and depression have a low omega-3 index

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 110, Issue , 2016, Pages 42-47

  Parletta, Natalie ^a   Zarnowiecki, Dorota ^a   Cho, Jihyun ^a   Wilson, Amy ^a   Procter, Nicholas ^a   Gordon, Andrea ^a   Bogomolova, Svetlana ^a   O'Dea, Kerin ^a   Strachan, John ^b   Ballestrin, Matt ^b   Champion, Andrew ^b   Meyer, Barbara J ^c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b Central Adelaide Local Health Network   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Cardiovascular disease; Depression; Mental illness; Omega 3; Omega 3 index; Polyunsaturated fatty acids; Schizophrenia

Indexed keywords

OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; AUSTRALIAN; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEPRESSION; FATTY ACID ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SCHIZOPHRENIA; AUSTRALIA; BLOOD; COMPLICATION; MIDDLE AGED; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; AUSTRALIA; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; METABOLIC SYNDROME; MIDDLE AGED; PILOT PROJECTS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84969972553     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2016.05.007     Document Type: Article

References (49)

1. World Health Organisation The World Health Report: Mental health - New Understandings, New hope 2001, World Health Organisation, Geneva.
2. Kessler R.C., Aguilar-Gaxiola S., Alonso J., Chatterji S., Lee S., Ormel J., Üstün T.B., Wang P.S. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) Surveys. Epidemiol. Psichiatr. Soc. 2009, 18:23-33.
3. Osborn D.P. The poor physical health of people with mental illness. West. J. Med. 2001, 175:329-332.
4. De Hert M., Correll C.U., Bobes J., Cetkovich-Bakmas M., Cohen D., Asai I., Detraux J., Gautam S., Möller H.-J., Ndetei D.M., Newcomer J.W., Uwakwe R., Leucht S. Physical illness in patients with severe mental disorders. I. Prevalance, impact of medications and disparities in health care. World Psychiatry 2011, 10:52-77.
5. Knol M.J., Twisk J.W., Beekman A.T., Heine R.J., Snoek F.J., Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49:837-845.
6. Pan A., Keum N., Okereke O.I., Sun Q., Kivimaki M. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012, 35:1171-1180.
7. N. Parletta, Y. Aljeesh, B.T. Baune, Health Behaviours, Knowledge, Life Satisfaction and Wellbeing in People with Mental Illness Across Four Countries and Comparisons with Normative Sample, (In preparation).
8. Osborn D.P.J., Nazareth I., King M.B. Physical activity, dietary habits and coronary heart disease risk factor knowledge amongst people with severe mental illness. Soc. Psychiatry Psychiatr. Epidemiol. 2007, 42:787-793.
9. Peet M. Diet, diabetes and schizophrenia: review and hypothesis. Br. J. Psychiatry 2004, 184:s102-s105.
10. Lai J.S., Hiles S., Bisquera A., Hure A.J., McEvoy M., Attia J. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am. J. Clin. Nutr. 2014, 99:181-197.
11. Peet M. International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. Br. J. Psychiatry 2004, 184:404-408.
12. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., Franklin B., Kris-Etherton P., Harris W.S., Howard B., Karanja N., Lefevre M., Rudel L., Sacks F., Van Horn L., Winston M., Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
13. James M.J., Sullivan T.R., Metcalf R.G., Cleland L.G. Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients. Br. J. Nutr. 2014, 112:812-820.
14. Rice H.B., Bernasconi A., Maki K.C., Harris W.S., Von Schacky C., Calder P.C. Conducting omega-3 trials with cardiovascular outcomes: proceedings of a workshop held at ISSFAL 2014. Prostaglandins Leukot. Essent. Fat. Acids 2014, 10.1016/j.plefa.2016.01.003.
15. Kris-Etherton P., Harris W.S., Appel L.J., Nutrition Committee, AHA Scientific Statement Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
16. Harris W.S., von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev. Med. 2004, 39:212-220.
17. Sinclair A.J., Crawford M.A. The accumulation of arachidonate and docosahexaenoate in the developing rat brain. J. Neurochem. 1972, 19:1753-1758.
18. Parletta N., Milte C.M., Meyer B. Nutritional modulation of cognitive function and mental health. J. Nutr. Biochem. 2013, 24:725-743.
19. Sinn N., Howe P.R.C. Mental health benefits of omega-3 fatty acids may be mediated by improvements in cerebral vascular function. Biosci. Hypotheses 2008, 1:103-108.
20. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck P.E., Marangell L.B., Richardson A.J., Lake J., Stoll A.L. Omega-3 fatty acids: evidence base for treatment and future research in psychiatry. J. Clin. Psychiatry 2006, 67:1954-1967.
21. Sinn N., Milte C., Howe P.R.C. Oiling the brain: a review of randomised controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients 2010, 2:128-170.
22. Amminger P.G., Schäfer M.R., Papageorgiou K., Klier C.M., Cotton S.M., Harrigan S.M., Mackinnon A., McGorry P., Berger G.E. Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders. Arch. Gen. Psychiatry 2010, 67:146-154.
23. Milte C., Sinn N., Howe P.R.C. Polyunsaturated fatty acid status in ADHD, depression and dementia: towards an omega-3 index for mental health?. Nutr. Rev. 2009, 67:573-590.
24. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom. Med. 2009, 71:171-186.
25. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
26. Gimeno D., Kivimaki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., Kumari M., Lowe G.D.O., Rumley A., Marmot M.G., Ferrie J.E. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 2009, 39:413-423.
27. Pasco J.A., Nicholson G.C., Williams L.J., Jacka F.N., Henry M.J., Kotowicz M.A., Schneider H.G., Leonard B.E., Berk M. Association of high-sensitivity C-reactive protein with de novo major depression. Br. J. Psychiatry 2010, 197:372-377.
28. Fernandes B.S., Steiner J., Bernstein H.-G., Dodd S., Pasco J.A., Dean O.M., Nardin P., Goncalves C.-A., Berk M. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol. Psychiatry 2015, 10.1038/mp.2015.87.
29. Meyer B.J., Kolanu N. Australian children are not consuming enough long-chain omega-3 polyunsaturated fatty acids for optimal health. Nutrition 2011, 27:1136-1140.
30. Meyer B.J., Mann N.J., Lewis J.L., Milligan G.C., Sinclair A.J., Howe P.R.C. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38:391-398.
31. Simopoulos A.P. Omega-3 fatty acids in wild plants, nuts and seeds. Asia Pac. J. Clin. Nutr. 2002, 11:S163-S173.
32. S. Bogomolova, D. Zarnowiecki, A. Wilson, A. Fielder, N. Procter, C. Itsiopoulos, K. O'Dea, J. Strachan, M. Ballestrin, A. Champion, N. Parletta, Dietary Intervention for People with Mental Illness in South Australia, (In preparation).
33. D. Zarnowiecki, J. Cho, A.M. Wilson, S. Bogomolova, A. Villani, C. Itsiopoulos, T. Niyonsenga, K. O'Dea, S. Blunden, B.J. Meyer, L. Segal, N. Parletta, A 6-month randomised controlled trial investigating effects of mediterranean-style diet and fish oil supplementation on dietary behaviour change, Mental and Cardiometabolic Health and Health-related Quality of Life in Adults with Depression (HELFIMED): Study Protocol, (In preparation).
34. Henry J.D., Crawford J.R. The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br. J. Clin. Psychol. 2005, 44:227-239.
35. Richardson J., Elsworth G., Iezzi A., Khan M.A., Mihalopoulos C., Schweitzer I., Herrman H. Increasing the sensitivity of the AQoL inventory for the evaluation of interventions affecting mental health 2011, Monash University.
36. Swierk M., Williams P.G., Wilcox J., Russell K.G., Meyer B.J. Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated fatty acid intake. Nutrition 2011, 27:641-646.
37. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 1986, 27:114-120.
38. Richardson J., Iezzi A., Khan M.A., Maxwell A. Validity and reliability of the assessment of quality of life (AQoL)-8D multi-attribute utility instrument. The Patient 2014, 7:85-96.
39. Crawford J.R., Cayley C., Lovibond P.F., Wilson P.H., Hartley C. Percentile norms and accompanying interval estimates from an Australian general adult population sample for self-report mood scales (BAI, BDI, CRSD, CES-D, DASS, DASS-21, STAI-X, STAI-Y, SRDS, and SRAS). Aust. Psychol. 2011, 46:3-14.
40. Lovibond S.H., Lovibond P.F. Manual for the Depression Anxiety Stress Scales 1995, Psychology Foundation, Sydney. 2nd ed.
41. Crawford J.R., Henry J.D. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br. J. Clin. Psychol. 2004, 43:245-265.
42. von Schacky C. Omega-3 index and cardiovascular health. Nutrients 2014, 6:799-814.
43. Sullivan B.L., Williams P.G., Meyer B.J. Biomarker validation of a long-chain omega-3 polyunsaturated fatty acid food frequency questionnaire. Lipids 2006, 41:845-850.
44. Kim Y.J., Jeong D.W., Lee J.G., Lee H.C., Lee S.Y., Kim Y.J., Yi Y.H., Park Y.S., Cho Y.H., Bae M.J., Choi E.J. Omega-3 index and smoking in patients with acute ST-elevation myocardial infarction taking statins: a case-control study in Korea. Lipids Health Dis. 2012, 11. 〈http://www.lipidworld.com/content/11/11/43〉.
45. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J. Affect. Disord. 2010, 126:303-311.
46. Frasure-Smith N., Lespérance F., Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry 2004, 55:891-896.
47. Agrawal R., Gomez-Pinilla F. 'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J. Physiol. 2012, 590:2485-2499.
48. Kuratko C.N., Salem N. Biomarkers of DHA status. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81:111-118.
49. Katan M.B., Deslypere J.P., van Birgelen A.P., Penders M., Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 1997, 38:2012-2022.